Improving Quality Based on the Joint Registry (IQ Joint)

October 26, 2021 updated by: PerlaJMarang, Leiden University Medical Center
Test whether an intervention, consisting of frequently feedback of performance outcomes and education will improve patient care, expressed in better functional outcomes, fewer complications and more quality improving interventions.

Study Overview

Detailed Description

A randomized controlled trial will be conducted where hospitals will be randomized to an early versus late group, stratified by teaching status as this might influence the time available for quality improvement. Randomization will be done using a computer generated randomization table in a 1:1 ratio. During the study only orthopedic surgeons performing THA and TKA will receive monthly feedback by email.

The intervention will consist of the following components:

  • Monthly feedback of performance outcomes;
  • Education on how to use joint registry data for quality improvement;
  • Create awareness by sending monthly feedback about performance; education and by asking what improvement activities have been introduced;
  • Hospitals will be linked to hospital with opposite performance outcomes to exchange information and find areas for improvement.

During the trial, the investigators will conduct monthly measurement on intermediate outcomes showing whether the intervention reaches the target group (process evaluation). The following measurements will take place:

  • Knowledge among orthopaedic surgeons on their recent performance and how that relates to others;
  • Number of quality improvement activities undertaken with the aim to improve the quality of care;
  • Planned improvement activities (e.g. record review to figure out why performance is not as good as in other centers) together with who is responsible and by which time;
  • Number of people attending the meetings, number of times a specific account has accessed the LROI site to ensure that information has reached the target group;
  • Survey among orthopaedic surgeons at the end of the intervention period on knowledge learned and the extent to which they think this is sustainable in daily practice.

In addition, the investigators will compare the outcomes between the early and the late group to test the effectiveness of the intervention, using the appropriate regression techniques. In the second period the investigators will test the sustainability of this approach in daily practice by comparing the outcomes within the early group with the first period, and compare with the late group to test whether outcomes in the sustainability phase are similar as when actively supported.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zuid-Holland
      • Leiden, Zuid-Holland, Netherlands, 2333 ZA
        • Leiden University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All Dutch orthopedic clinics where hip- and knee replacement surgery is performed who agree to participate will be randomized.

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Intervention Group
Half of the participating hospitals will be in the intervention group for the first 6 months. The intervention will switch to the control group after the 6 months.
- Give monthly feedback from LROI-data (revision rate & patient reported outcome measures) as well as other outcomes from the participating hospital (length-of-stay, readmission and complications), combined with education on how to use this information for improvement. This will be send monthly by email to the intervention group. Further, hospitals with worse performance for a certain outcome will be linked to hospitals with good performance for this outcome.
NO_INTERVENTION: Control Group
Half of the participating hospitals will be in the control group for the first 6 months. The control group will undergo the intervention in the second 6 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival (yes/no)
Time Frame: 1 year follow-up during trial
Patient survival after HA/TKA surgery
1 year follow-up during trial
1-year revision rate (%)
Time Frame: 1 year follow-up during trial
Number of revisions performed within one year adjusted for patient characteristics
1 year follow-up during trial
Prolonged length-of stay (yes/no)
Time Frame: 1 year follow-up during trial
Prolonged length-of-stay in the overall upper quartile
1 year follow-up during trial
Readmission (yes/no)
Time Frame: 1 year follow-up during trial
Readmission within 30 days after discharge
1 year follow-up during trial
Number of Complications
Time Frame: 1 year follow-up during trial
Number of complications
1 year follow-up during trial
Composite outcome measure (Textbook Outcome)
Time Frame: 1 year follow-up during trial
Including: Survival; 1-year revision rate; Length-of-Stay and Readmission.
1 year follow-up during trial

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Quality Improvement Initiatives
Time Frame: 1 year follow-up during trial
Number of quality improvement Initiatives with the aim to improve the quality of care
1 year follow-up during trial

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Perla Marang-van de Mheen, Dr., Leiden University Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2019

Primary Completion (ACTUAL)

May 31, 2021

Study Completion (ACTUAL)

May 31, 2021

Study Registration Dates

First Submitted

August 8, 2019

First Submitted That Met QC Criteria

August 12, 2019

First Posted (ACTUAL)

August 13, 2019

Study Record Updates

Last Update Posted (ACTUAL)

October 27, 2021

Last Update Submitted That Met QC Criteria

October 26, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • G18.140
  • VRF2018-001 (OTHER_GRANT: Van Rens Foundation)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This is about the performance of hospitals. The individual performance of a hospital will not be announced.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Arthropathy

Clinical Trials on Monthly feedback, education and linking hospitals

3
Subscribe